U0126

From WikiMD's Medical Encyclopedia

U0126


U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. U0126 functions as a highly potent, selective and cell-permeable inhibitor of MEK1 and MEK2. It is often used in cellular biology to understand cell signaling, including apoptosis, proliferation and differentiation.

Mechanism of Action[edit]

U0126 inhibits MEK1 and MEK2 by binding to the inactive forms of each enzyme, preventing their activation by upstream kinases. This inhibition prevents the phosphorylation of ERK1/2, thus blocking the activation of the MAPK/ERK pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

Applications[edit]

U0126 has been used in a variety of research applications. It is often used in studies of cell signaling to inhibit the MAPK/ERK pathway. This can help researchers understand the role of this pathway in various cellular processes, such as cell growth and apoptosis. U0126 has also been used in studies of cancer, as the MAPK/ERK pathway is often dysregulated in cancer cells.

Safety and Toxicity[edit]

As with any chemical, safety precautions should be taken when handling U0126. It is recommended to avoid contact with skin and eyes, and to use in a well-ventilated area. The toxicity of U0126 is not fully understood, and it is recommended to handle with care.

See Also[edit]

Stub icon
   This article is a biochemistry stub. You can help WikiMD by expanding it!



This article is a stub related to chemistry. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.